Actively Recruiting
Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
Led by NYU Langone Health · Updated on 2026-04-09
353
Participants Needed
1
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigators will conduct a hybrid type 1 effectiveness-implementation randomized controlled trial (RCT) to evaluate the effectiveness of iMatter2 versus usual care on reduction in HbA1c at 12-months (primary outcome) among patients with Type 2 diabetes (T2D).
CONDITIONS
Official Title
Novel Digital Patient-Reported Outcomes Tool for Diabetes Management
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be a full-time primary care provider (MD/DO, NP) practicing at participating family health centers or faculty group practices and provide care to at least five patients with Type 2 Diabetes
- Have a diagnosis of Type 2 Diabetes for 6 months or more
- Have uncontrolled Type 2 Diabetes with HbA1c greater than 7% documented on at least two visits in the past year
- Be fluent in English or Spanish
- Be willing to send and receive text messages
- Be 18 years of age or older
You will not qualify if you...
- Refuse or are unable to provide informed consent
- Have acute renal failure, end stage renal disease (ESRD), dialysis, renal transplantation, or other ESRD-related services
- Have significant psychiatric conditions or substance abuse as documented in medical records
- Are pregnant or planning to become pregnant within 12 months
- Currently participate in another Type 2 Diabetes study
- Plan to discontinue care at the clinic within the next 12 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
NYU Langone Health
New York, New York, United States, 10016
Actively Recruiting
Research Team
P
Priscilla D'antico
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here